Navigation Links
Organovo to Present at the 24th Annual Oppenheimer Healthcare Conference
Date:12/2/2013

SAN DIEGO, Dec. 2, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), a three-dimensional biology company focused on delivering breakthrough 3D bioprinting technology, has been invited to present at the 24th Annual Oppenheimer Healthcare Conference, which will be held in New York December 10-11, 2013.

Organovo's Chairman and Chief Executive Officer, Keith Murphy, will be presenting on Wednesday, December 11, at 2:45pm ET.

The objective of the Oppenheimer 24th Annual Healthcare Conference is to provide investors a broad spectrum of public and private healthcare companies spanning all major sectors of the healthcare industry, including bio & specialty pharmaceuticals; biotechnology; medical devices; healthcare facilities; life science tools and diagnostics; healthcare information technology and distribution, and healthcare providers and servicers.  The conference will be held at the Crowne Plaza Hotel – New York.

About Organovo Holdings, Inc.
Organovo designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications. The Company is collaborating with pharmaceutical and academic partners to develop human biological disease models in three dimensions. These 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. In addition to numerous scientific publications, the Company's technology has been featured in The Wall Street Journal, Time Magazine, The Economist, and numerous others. Organovo is changing the shape of medical research and practice. Learn more at www.organovo.com.

Safe Harbor Statement
Any statements contained in this press release that do not describe historical facts may constitute forward-looking s
'/>"/>

SOURCE Organovo Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Organovo to Present at the 25th Annual Piper Jaffray Healthcare Conference
2. KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH
3. Population Council to present more than 40 studies at International Conference on Family Planning
4. Experts from NYU Langone present new research at American College of Rheumatology 2013 Annual Meeting
5. Common bias known as the endowment effect not present in hunter-gatherer societies
6. Pest control presentations at Entomology 2013
7. Trovagene Announces Abstracts to be Presented at Molecular Targets and Cancer Therapeutics Conference
8. Array BioPharma to Present at the NewsMakers in the Biotech Industry Conference
9. New research on potential avocado health benefits presented at International Congress of Nutrition
10. Cytos Biotechnology Presents Additional Results From Phase 2a Study of CYT003 for the Treatment of Allergic Asthma
11. Yin-yang effect of sodium and chloride presents salt conundrum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2015)... 2015  HYPR Corp. today announced it has ... Alliance tm , an industry consortium transforming online ... share technology and collaborate to deliver open specifications ... secure and private, and easier to use. ... protects sensitive user information and eliminates the dependency ...
(Date:4/10/2015)... DUBLIN , April 10, 2015 ... the addition of the "Security Competitive Profiles - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to ... solutions to the market, with a company focus on ... solution anticipated. Winning opportunities in the ...
(Date:4/2/2015)... Germany , April 2, 2015 ... fingerprint tests DERMALOG by far outperforms the strongest ... always maintaining high accuracy, the system is capable ... Hence, the speed proves up to be ten ... faster than its runner-up performance.      ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3NEC Security Competitive Profile 2015 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
... to play a major role in the studies ... a life-threatening parasitic disease that kills nearly one ... advanced our understanding of malaria, new models are ... Institute for Mathematical and Biological Synthesis (NIMBioS) is ...
... 18, 2011 -- Physicists and bioengineers have developed an ... a worm just by shining a tightly focused beam ... The pioneering optogenetic research, by a team at Harvard ... Massachusetts Medical School, is described this week in the ...
... the first view of DNA damage throughout the entire ... a valuable new insight into the development and treatment ... Dr Simon Reed and Dr Yumin Teng from Cardiff ... a unique way of measuring DNA damage frequency using ...
Cached Biology News:Malaria modeling and control focus of workshop 2Sharply focused on neurons, light controls a worm's behavior 2New technology provides first view of DNA damage within entire human genome 2
(Date:5/20/2015)... , May 20, 2015  Marc Tessier-Lavigne, president ... gift of $100 million from The Marie-Josée and ... new laboratory building that will be the centerpiece ... Marie-Josée and Henry R. Kravis Research Building, two ... Drive, spanning approximately three city blocks following the ...
(Date:5/20/2015)... May 20, 2015  Cypher Genomics, Inc., a ... with Celgene Corporation to apply Cypher,s Coral TM ... associate with patient response to innovative medicines. The ... help accelerate patient access to the right medicine ... research and development and potentially inform new companion ...
(Date:5/20/2015)... 19, 2015 Research and Markets ... the "Bone Morphogenetic Proteins Market (Types : ... and Oral - Maxillofacial) - Global Industry Analysis, ... 2022" report to their offering. ... based on the types of recombinant BMPs, applications, ...
(Date:5/20/2015)... (PRWEB) May 20, 2015 Optivia ... assay services for Drug-Drug Interactions (DDI), Metabolism and ... a world leader in assessing impact of drugs ... Pharmacology supported by biosimulation, announced today that they ... allows both companies to expand their product and ...
Breaking Biology Technology:The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 2The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 3The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 4Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers 2Global Bone Morphogenetic Proteins Market Industry Analysis 2014 - 2022 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 3
... Louvain, Belgium Cancer is the major cause of ... predict that, by about 2010, cancer will be the ... VIB scientists connected to the Katholieke Universiteit Leuven, in ... studying the anti-cancer action of anti-PLGF. This substance appears ...
... Delft University of Technologys Kavli Institute of Nanoscience and ... succeeded in controlling the spin of a single electron ... for a much simpler realization of the building blocks ... publish their work in Science Express on Thursday 1 ...
... BioFuel Energy Corp. (Nasdaq:,BIOF) announced today that ... Wednesday, November 7, 2007, after the market closes. ... plans to host a conference call on Thursday, ... discuss the third quarter results. To,participate, please dial ...
Cached Biology Technology:On the road to a new cancer therapy -- starving the tumor 2On the road to a new cancer therapy -- starving the tumor 3Delft University of Technology rotates electron spin with electric field 2
...
ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....
... MasterAmp™ Taq DNA Polymerase is a ... aquaticus. Having optimal activity at temperatures ... thermostable enzyme used for PCR and ... purpose. The enzyme has an intrinsic ...
Rabbit anti Xanthine Oxidase Xanthine Oxidase, Bovine Buttermilk...
Biology Products: